Herzelia, Israel

Moshe Hod


 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Moshe Hod

Introduction

Moshe Hod is a notable inventor based in Herzliya, Israel, recognized for his significant contributions to the field of maternal-fetal medicine. With a total of three patents to his name, he has focused on developing methods and tools that enhance the monitoring and diagnosis of pregnancy-related complications.

Latest Patents

Hod's latest patents include groundbreaking methods for identifying and monitoring pregnant women at risk of preeclampsia. These methods utilize the expression pattern of non-coding RNAs in body fluids to provide critical information for identifying pregnant women at risk during the early stages of pregnancy. Additionally, he has developed methods and compositions for diagnosing complications of pregnancy, which include identifying subjects at risk of developing issues such as preeclampsia or preterm labor. The compositions involved in these inventions consist of microRNAs and associated nucleic acids.

Career Highlights

Throughout his career, Moshe Hod has worked with several prominent companies, including Mor Research Applications Ltd. and Rosetta Genomics Ltd. His work in these organizations has allowed him to advance his research and contribute to innovative solutions in the medical field.

Collaborations

Hod has collaborated with notable colleagues, including Yaron Goren and Shlomit Gilad, which has further enriched his research and development efforts.

Conclusion

Moshe Hod's innovative work in the field of maternal-fetal medicine has led to significant advancements in the identification and management of pregnancy-related complications. His contributions continue to impact the health and well-being of pregnant women.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…